BioSpace News Archive

BioMidwest

New Findings Show Artificial Intelligence Software Improves Breast Cancer Detection and Physician Accuracy

Koios Medical, Inc. announced results from an evaluation of the company’s FDA cleared artificial intelligence medical device software to analyze breast ultrasound images

December 19, 2019
·
4 min read
Biotech Beach

PharmaCyte Biotech Provides Details on Quarterly Shareholder Update

The company’s resources are fully engaged in completing its 10-Q for the period ending October 31, 2019 and are being dedicated to submitting its Investigational New Drug application (IND) as quickly and correctly as possible.

December 19, 2019
·
3 min read
World first treatment with ‘acoustic cluster therapy’ to improve chemotherapy delivery

- First patient in the world treated with new acoustic cluster therapy through a clinical trial - Acoustic cluster therapy combines microbubbles and microdroplets - New therapy could improve targeting of chemotherapy and reduce doses

December 19, 2019
·
8 min read
Drug Development

Topas Therapeutics Announces First Patient Enrolled in Phase 1 Trial with TPM203 in Pemphigus Vulgaris

• First program from the Topas platform to enter clinical testing • TPM203 is one of several proprietary programs being developed by Topas • Pemphigus vulgaris is an orphan indication that currently has no cure

December 19, 2019
·
4 min read
Global Breast Biopsy Devices Market 2019-2023 | Evolving Opportunities with Argon Medical Devices, Inc. and Pfizer Inc. | Technavio

Technavio has announced its latest market research report titled global breast biopsy devices market 2019-2023.

December 19, 2019
·
5 min read
Business

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2019

Avivagen Inc. reported its audited financial results for the year ended October 31, 2019.

December 19, 2019
·
5 min read
Drug Development

Astellas and Seattle Genetics Win Accelerated Approval for Bladder Cancer Drug

The FDA granted Astellas Pharma and Seattle Genetics accelerated approval for Padcev, a first-of-its-kind treatment for adult patients with metastatic urothelial bladder cancer.

December 19, 2019
·
3 min read
·
Alex Keown
Business

Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials

Arcus Biosciences and Genentech, a Roche company, are partnering on two clinical trials for colorectal and pancreatic cancer. They will evaluate Arcus’s AB928 in various combinations.

December 19, 2019
·
2 min read
·
Mark Terry
Drug Development

Minerva MDD Treatment Fails Mid-Stage Trial, Company Has No Further Development Plans

Shares of Minerva Neurosciences are down more than 22% in premarket trading after the company announced late Wednesday that its Phase IIb major depressive disorder (MDD) trial failed to meet primary and key secondary endpoints.

December 19, 2019
·
2 min read
·
Alex Keown
Lone Star Bio

Researchers ID Possible Mechanism to Prevent the Spread of Melanoma

What they found was that melanoma cells are more likely to metastasize through the body if their cells have high concentrations of MCT1 on their cell surface.

December 19, 2019
·
2 min read
·
Mark Terry